POTASSIUM CITRATE + MAGNESIUM CITRATE + PYRIDOXINE HYDROCHLORIDE SYRUP

Therapeutic Indication

Renal calculi (kidney stones)

Prevention of recurrent kidney stones

Urinary alkalinization

Burning micturition

Urinary tract support

+91 85919 78885

POTASSIUM CITRATE + MAGNESIUM CITRATE + PYRIDOXINE HYDROCHLORIDE

Syrup

This syrup is a combination of urinary alkalizers and a vitamin formulated for the management and prevention of kidney stones. Potassium Citrate alkalinizes urine and increases urinary citrate levels, thereby preventing the formation and aggregation of calcium oxalate stones. Magnesium Citrate helps reduce oxalate absorption and inhibits stone formation. Pyridoxine Hydrochloride (Vitamin B6) reduces oxalate production, further lowering the risk of stone formation. The formulation helps maintain optimal urinary pH, reduces recurrence of stones, and provides symptomatic relief from urinary discomfort.

Speciality	Urology \| Nephrology
Tags	Kidney Stone Care \| Urinary Alkalizer \| Renal Support
Strength	Potassium Citrate IP – 1100 mg / 5 ml Magnesium Citrate USP – 375 mg / 5 ml Pyridoxine Hydrochloride – 20 mg / 5 ml
Packing Size	100 ml Bottle 200 ml Bottle

Check all Tablet Range

Click to know More

Mechanism

Potassium Citrate
Alkalinizes urine and increases citrate levels, inhibiting crystal formation and growth.
Magnesium Citrate
Binds oxalate in the intestine and reduces urinary stone formation.
Pyridoxine Hydrochloride (Vitamin B6)
Reduces endogenous oxalate production, lowering risk of calcium oxalate stones.

Side Effects

Nausea
Abdominal discomfort
Vomiting

Pharmacokinetics

Absorption: Oral absorption; varies with GI status .
Distribution: Potassium → intracellular fluid; Magnesium → bone/muscle; Pyridoxine → tissues, CNS .
Metabolism: Pyridoxine → converted to pyridoxal phosphate
Excretion: Potassium & Magnesium → renal; Pyridoxine → urine
Half‑life: Potassium/Magnesium → hours; Pyridoxine ~15–20 days

Contraindication

Hypersensitivity to any component
Severe renal impairment
Hyperkalemia

Dosage

As directed by the physician.

DRUG INTERACTIONS

Potassium → interacts with ACE inhibitors, ARBs, potassium‑sparing diuretics (risk of hyperkalemia).
Magnesium → interacts with tetracyclines, fluoroquinolones (reduces absorption).
Pyridoxine → interacts with levodopa (reduces efficacy unless combined with carbidopa).

Warning and Precautions

Shake well before use
Maintain adequate hydration
Monitor serum electrolytes during prolonged use
Use cautiously in renal or cardiac conditions
Do not exceed recommended dosage
Store in a cool, dry place
Keep out of reach of children

All product details on this website are for reference and informational purposes only and are not directed at patients or consumers.
As a contract manufacturer, DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all liability arising from reliance on this information.
Please consult a healthcare professional before using any medicinal product.